AMS 800™ Urinary Control System
This system restores continence with an occlusive cuff and a corresponding pump that the patient controls. With over 150,000 patients treated,1 the AMS 800™ Urinary Control System is the leading treatment for male stress urinary incontinence (SUI) following prostate surgery.
The AMS 800TM Urinary Control System is a completely concealed, implantable, fluid-filled, solid silicone elastomer device that treats male SUI resulting from internal sphincter deficiency. It mimics normal sphincter function by opening and closing the urethra at the control of the patient.2
Features + Benefits
This system offers customizable treatment options based on the patient’s physical condition, with components tailored to fit their anatomy. System components and accessories include:
· Occlusive Cuff
· Pressure Regulating Balloon
· Control Pump
· Accessory Kit
· Quick Connect Assembly Tool
· Insertion Package
· Deactivation Package
With our Healthcare Professional Resource Center, we've made it easier than ever to access technical, surgical and patient education material whenever, and wherever, you are. To get started, simply click Learn More below to find the product or disease state you would like to review.
* This material is graphic and intended for viewing only by healthcare professionals.Learn More
In one study of 50 patients, 90% reported satisfaction.3 92% would have the AMS 800TM Urinary Control System placed again.3 96% would recommend it to a friend.1 Published clinical studies show that 59%-90% used 0-1 pad per day after the procedure.4
The AMS 800TM Urinary Control System (or Artificial Urinary Sphincter) is intended to treat urinary incontinence due to reduced outlet resistance (Intrinsic Sphincter Deficiency) following prostate surgery. The device is contraindicated in patients who are determined to be poor surgical candidates, have an irreversibly blocked lower urinary tract, have irresolvable detrusor hyperreflexia or bladder instability, (or for the AMS 800TM with InhibiZoneTM have a known sensitivity or allergy to rifampin, minocycline, or other tetracyclines).
Patients with urinary tract infections, diabetes, spinal cord injuries, open sores, or regional skin infections may have increased infection risk. Device-tissue erosion may occur. Proper patient evaluation, selection, and counseling of realistic expectations should occur. Possible adverse events include, but are not limited to, compromised device function, pain/discomfort, delayed wound healing, migration, and recurrent incontinence.
Prior to using these devices, please review the Instructions for Use for a complete listing of indications, contraindications, warnings, precautions, and potential adverse events.
Healthcare Professional Resource Center
To help you and your patients optimize your experience with AMS products,
we provide many helpful tools.
Here you’ll find a listing of indications, contraindications, warnings, precautions, and potential adverse events, as well as additional product-specific labeling.View Instructions for Use
1. Data on file.
2. AMS 800TM Urinary Control System Instructions for Use. American Medical Systems, Inc. 2012.
3. Montague, DK. Artificial urinary sphincter: long-term results and patient satisfaction. Adv Urol. 2012:835290. doi:10.1155/2012/835290.
4. Kahlon B, Baverstock RJ, Carlson K. Quality of life and patient satisfaction after artificial urinary sphincter. Can Urol Assoc J. 2011;5(4):268-272.